Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution (Q28194218)

Prostaglandins and Other Lipid Mediators

Europe PubMed Central

title

Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution (English)

0 references

0 references

1 reference

1

Charles N Serhan

0 references

language of work or name

English

0 references

publication date

August 2002

0 references

published in

0 references

volume

68-69

0 references

page(s)

433-55

0 references

cites work

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Sites of action for future therapy: an adenosine-dependent mechanism by which aspirin retains its antiinflammatory activity in cyclooxygenase-2 and NFkappaB knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin biosynthesis and its impact in inflammatory and vascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipid mediator networks in cell signaling: update and impact of cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Regulation of leukocyte trafficking by lipoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Aspirin as prophylaxis against colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protoco

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipid mediator class switching during acute inflammation: signals in resolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

On the mechanism of transcellular lipoxin formation in human platelets and granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Adhesion promotes transcellular leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: inhibition by antibodies against CD18 and L-selectin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Recent progress in the cellular and molecular biology of prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

The scent of a phagocyte: Advances on leukotriene b(4) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Phospholipid bilayers enhance the stability of leukotriene A4 and epoxytetraenes: stabilization of eicosanoids by liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

The discovery of aspirin: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin A4 inhibits cholinergic neurotransmission through nitric oxide generation in the rabbit trachea

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

TH2 and 'TH2-like' cells in allergy and asthma: pharmacological perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxins A4 and B4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin generation by permeabilized human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin synthase activity of human platelet 12-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Enzymatic Formation and Regulatory Function of Lipoxins and Leukotriene B4 in Rat Kidney Mesangial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin formation in human nasal polyps and bronchial tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Conversion of 5,6-dihydroxyeicosatetraenoic acids. A novel pathway for lipoxin formation by human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Endogenous sulfidopeptide leukotriene synthesis and 12-lipoxygenase activity in bullfrog (Rana catesbeiana) erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Agonist-induced lipoxin A4 generation: Detection by a novel lipoxin A4-ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

The benefits of aspirin in acute myocardial infarction. Still a well-kept secret in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Formation and proliferative effects of lipoxins in human bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin A4Analogues Inhibit Leukocyte Recruitment toPorphyromonas gingivalis: A Role for Cyclooxygenase-2 and Lipoxins in Periodontal Disease†

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Mutations of serine 236-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

Lipoxins: revelations on resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900047-3

7 January 2021

10.1016/S0090-6980(02)00047-3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2623978

2623978

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference